{"disease":{"id":"respiratory-disease","name":"respiratory disease"},"drugs":{"marketed":[{"drug_id":"nirsevimab","indication_name":"Prevention of respiratory Syncytial Virus (RSV) lower respiratory tract disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Beyfortus","generic_name":"NIRSEVIMAB","company_name":"AstraZeneca","drug_phase":"marketed","molecular_target":"RSV","drug_class":"Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]","quality_score":10,"revenue":"800","mechanism":"BEYFORTUS is a monoclonal antibody that targets RSV."},{"drug_id":"respiratory-syncytial-virus-prefusion-f-subunit-vaccine","indication_name":"Prevention of severe lower respiratory tract disease caused by respiratory syncytial virus (RSV) in infants with a high risk of RSV disease due to prematurity.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Respiratory Syncytial Virus Prefusion F Subunit Vaccine","generic_name":"respiratory-syncytial-virus-prefusion-f-subunit-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Respiratory Syncytial Virus (RSV)","drug_class":"Vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"respiratory-syncytial-virus-prefusion-f-subunit-vaccine","indication_name":"Prevention of severe lower respiratory tract disease caused by respiratory syncytial virus (RSV) in infants with a high risk of RSV disease due to certain chronic lung conditions.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Respiratory Syncytial Virus Prefusion F Subunit Vaccine","generic_name":"respiratory-syncytial-virus-prefusion-f-subunit-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Respiratory Syncytial Virus (RSV)","drug_class":"Vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"respiratory-syncytial-virus-prefusion-f-subunit-vaccine","indication_name":"Prevention of severe lower respiratory tract disease caused by respiratory syncytial virus (RSV) in infants with a high risk of RSV disease due to certain heart conditions.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Respiratory Syncytial Virus Prefusion F Subunit Vaccine","generic_name":"respiratory-syncytial-virus-prefusion-f-subunit-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Respiratory Syncytial Virus (RSV)","drug_class":"Vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"beyfortus","indication_name":"Prevention of respiratory Syncytial Virus (RSV) lower respiratory tract disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Beyfortus","company_name":"National Institute of Allergy and Infectious Diseases (NIAID)","drug_phase":"marketed","molecular_target":"Fusion glycoprotein F0","drug_class":"","quality_score":13,"revenue":null,"mechanism":null},{"drug_id":"rsvpref-vaccine","indication_name":"Prevention of severe lower respiratory tract disease caused by respiratory syncytial virus (RSV) in infants with a high risk of RSV-associated hospitalization due to prematurity.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"RSVpreF Vaccine","generic_name":"rsvpref-vaccine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"RSV","drug_class":"vaccine","quality_score":22,"revenue":null,"mechanism":""},{"drug_id":"rsvpref-vaccine","indication_name":"Prevention of severe lower respiratory tract disease caused by respiratory syncytial virus (RSV) in young children with a history of premature birth or bronchopulmonary dysplasia.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"RSVpreF Vaccine","generic_name":"rsvpref-vaccine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"RSV","drug_class":"vaccine","quality_score":22,"revenue":null,"mechanism":""},{"drug_id":"rsvpref-mdv","indication_name":"Prevention of RSV lower respiratory tract disease in neonates at high risk of RSV disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"RSVpreF MDV","generic_name":"rsvpref-mdv","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"RSV F protein","drug_class":"Monoclonal antibody","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"rsvpref-mdv","indication_name":"Prevention of RSV lower respiratory tract disease in infants and children at high risk of RSV disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"RSVpreF MDV","generic_name":"rsvpref-mdv","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"RSV F protein","drug_class":"Monoclonal antibody","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"nirsevimab-alip","indication_name":"Prevention of respiratory Syncytial Virus (RSV) lower respiratory tract disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"BEYFORTUS","generic_name":"NIRSEVIMAB-ALIP","company_name":"ASTRAZENECA AB","drug_phase":"marketed","molecular_target":"Fusion glycoprotein F0","drug_class":"Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"rsvpref","indication_name":"Prevention of RSV lower respiratory tract disease in neonates at high risk of RSV disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"RSVpreF","generic_name":"rsvpref","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"RSV F protein","drug_class":"Monoclonal antibody","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"rsvpref","indication_name":"Prevention of RSV lower respiratory tract disease in infants and children at high risk of RSV disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"RSVpreF","generic_name":"rsvpref","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"RSV F protein","drug_class":"Monoclonal antibody","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"rsv-prefusion-f-protein-based-vaccine","indication_name":"Prevention of respiratory syncytial virus (RSV) disease in adults aged 60 years and older","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"RSV prefusion F protein-based vaccine","generic_name":"rsv-prefusion-f-protein-based-vaccine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Respiratory syncytial virus fusion (F) protein","drug_class":"Viral protein subunit vaccine","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"rsvpref-120-g","indication_name":"Prevention of RSV lower respiratory tract disease in neonates at high risk of RSV disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"RSVpreF 120 µg","generic_name":"rsvpref-120-g","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Prefusion form of the RSV F protein","drug_class":"Recombinant subunit vaccine","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"sodium-succinate","indication_name":"Respiratory Diseases","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"SODIUM SUCCINATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"rsvpref-120-g","indication_name":"Prevention of RSV lower respiratory tract disease in infants and children at high risk of RSV disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"RSVpreF 120 µg","generic_name":"rsvpref-120-g","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Prefusion form of the RSV F protein","drug_class":"Recombinant subunit vaccine","quality_score":40,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":16,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05483881","title":"the Effects of Air Pollution on Respiratory Diseases in Children","phase":"","overall_status":"UNKNOWN","enrollment_count":2000000,"lead_sponsor_name":"Beijing Children's Hospital","has_results":false},{"nct_id":"NCT07196917","title":"Prospective Cohort of Integrated Traditional Chinese and Western Medicine in China","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000000,"lead_sponsor_name":"Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT05321433","title":"Tobacco Use and the Risk of COVID-19 and Adverse Outcomes","phase":"","overall_status":"COMPLETED","enrollment_count":757585,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT05248412","title":"The Long-term Spill-over Impact of COVID-19 on Health and Healthcare of People With Non-communicable Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":250000,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT07416266","title":"Lower Respiratory Tract Infections Managed in Primary Care in France","phase":"","overall_status":"COMPLETED","enrollment_count":230066,"lead_sponsor_name":"Hôpital Raymond Poincaré","has_results":false},{"nct_id":"NCT02681848","title":"What Are the Effects of Varenicline Compared With Nicotine Replacement Therapy on Long Term Smoking Cessation and Clinically Important Outcomes?","phase":"","overall_status":"UNKNOWN","enrollment_count":180000,"lead_sponsor_name":"University of Bristol","has_results":false},{"nct_id":"NCT05013944","title":"AnovaOS Network Powered Patient Registry","phase":"","overall_status":"RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Anova Enterprises, Inc","has_results":false},{"nct_id":"NCT04125888","title":"Impact of AIT on Allergic Rhinitis and Asthma","phase":"","overall_status":"COMPLETED","enrollment_count":92048,"lead_sponsor_name":"ALK-Abelló A/S","has_results":false},{"nct_id":"NCT03294473","title":"Centralized Reminder Recall - Flu RCT2","phase":"NA","overall_status":"COMPLETED","enrollment_count":70190,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT07047768","title":"Artificial Intelligence for Respiratory Infections SEverity Prediction","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":52000,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT07026370","title":"Chinese Population Health and Multimorbidity Study","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":50991,"lead_sponsor_name":"China-Japan Friendship Hospital","has_results":false},{"nct_id":"NCT07090200","title":"Rehabilitation Intervention for COPD Combined With Cardiovascular and Cerebrovascular Diseases","phase":"NA","overall_status":"RECRUITING","enrollment_count":50000,"lead_sponsor_name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT05780099","title":"Prospective Observational Study to Characterize Patients Treated at Internal Medicine Clinics","phase":"","overall_status":"RECRUITING","enrollment_count":50000,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT03934957","title":"Hamburg City Health Study - a German Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":45000,"lead_sponsor_name":"Universitätsklinikum Hamburg-Eppendorf","has_results":false},{"nct_id":"NCT04908683","title":"A Study of an Adenovirus Serotype 26 Pre-fusion Conformation-stabilized F Protein (Ad26. RSV. preF) Based Respiratory Syncytial Virus (RSV) Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":25236,"lead_sponsor_name":"Janssen Vaccines & Prevention B.V.","has_results":true},{"nct_id":"NCT03739112","title":"Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderly","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":12794,"lead_sponsor_name":"Medicago","has_results":true},{"nct_id":"NCT02111564","title":"A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":12024,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":true},{"nct_id":"NCT06227468","title":"A Clinical Study to Map the HLA Genomic Region in the Greek Population","phase":"","overall_status":"RECRUITING","enrollment_count":12000,"lead_sponsor_name":"Athens LifeTech Park","has_results":false},{"nct_id":"NCT03301051","title":"Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":10160,"lead_sponsor_name":"Medicago","has_results":true},{"nct_id":"NCT04855604","title":"The Status Quo of Diagnosis and Treatment of Pediatric Outpatients With Respiratory Diseases","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Beijing Children's Hospital","has_results":false},{"nct_id":"NCT05169463","title":"NETTUNIT - Italy-Tunisia Cross-border Environmental network_1","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Istituto per la Ricerca e l'Innovazione Biomedica","has_results":false},{"nct_id":"NCT05681962","title":"Practice of Oxygenation and Respiratory Support During Fiberoptic Bronchoscopy","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"University Magna Graecia","has_results":false},{"nct_id":"NCT04031651","title":"Key Specialized Monitoring of Clinical Safety of Pudilan Xiaoyan Oral Liquid in the Real World","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"China Academy of Chinese Medical Sciences","has_results":false},{"nct_id":"NCT04256720","title":"The Multi-Ethnic Lifestyle Study","phase":"","overall_status":"UNKNOWN","enrollment_count":9500,"lead_sponsor_name":"University of Leicester","has_results":false},{"nct_id":"NCT03931226","title":"Impact of Spa Treatments on the Consumption of Care in Children","phase":"","overall_status":"COMPLETED","enrollment_count":8372,"lead_sponsor_name":"University Hospital, Toulouse","has_results":false},{"nct_id":"NCT05097677","title":"Follow-up of Covid-19 Long Term Sequelae","phase":"","overall_status":"COMPLETED","enrollment_count":7599,"lead_sponsor_name":"Azienda Ospedaliera Universitaria Integrata Verona","has_results":false},{"nct_id":"NCT05766046","title":"Lung Cancer Prevention Screening Programme in Italy","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":7324,"lead_sponsor_name":"Ugo Pastorino","has_results":false},{"nct_id":"NCT06953180","title":"Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction","phase":"","overall_status":"RECRUITING","enrollment_count":6720,"lead_sponsor_name":"Asfendiyarov Kazakh National Medical University","has_results":false},{"nct_id":"NCT04367740","title":"ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":6313,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false},{"nct_id":"NCT04497753","title":"An Epidemiological Investigation on Correct Wearing of Mask by Hood Test","phase":"","overall_status":"COMPLETED","enrollment_count":6000,"lead_sponsor_name":"Fuwai Yunnan Cardiovascular Hospital","has_results":false},{"nct_id":"NCT04627623","title":"Prevalence and Risk Factors of COVID-19 in the Upper Silesian Agglomeration","phase":"","overall_status":"UNKNOWN","enrollment_count":6000,"lead_sponsor_name":"Medical University of Silesia","has_results":false},{"nct_id":"NCT04497675","title":"An Epidemiological Investigation on Correct Wearing of Mask by Direct Spray Test","phase":"","overall_status":"COMPLETED","enrollment_count":6000,"lead_sponsor_name":"Fuwai Yunnan Cardiovascular Hospital","has_results":false},{"nct_id":"NCT04474028","title":"An Epidemiological Investigation on the Correct Wearing of Face Mask","phase":"","overall_status":"COMPLETED","enrollment_count":6000,"lead_sponsor_name":"Fuwai Yunnan Cardiovascular Hospital","has_results":false},{"nct_id":"NCT03982199","title":"A Study of an Ad26.RSV.preF-based Regimen in the Prevention of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)-Confirmed Respiratory Syncytial Virus (RSV)-Mediated Lower Respiratory Tract Disease in Adults Aged 65 Years and Older","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":5815,"lead_sponsor_name":"Janssen Vaccines & Prevention B.V.","has_results":true},{"nct_id":"NCT05244356","title":"Health Communication to Influence COVID-19 Vaccination Intent and Message Propagation","phase":"NA","overall_status":"COMPLETED","enrollment_count":5784,"lead_sponsor_name":"Clinical Research Centre, Malaysia","has_results":false},{"nct_id":"NCT02546479","title":"Follow-Up Study of People Treated for Scoliosis","phase":"","overall_status":"COMPLETED","enrollment_count":5573,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT00014859","title":"Epidemiology of Surfactant Protein-B Deficiency","phase":"","overall_status":"COMPLETED","enrollment_count":5176,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT07445763","title":"TARSILA Real-World Evidence Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Inova Medical","has_results":false},{"nct_id":"NCT06499480","title":"Italian Registry of Allergen ImmunoTherapy","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Società Italiana di Allergologia, Asma e Immunologia Clinica","has_results":false},{"nct_id":"NCT07363980","title":"Coronary Computed Tomography Angiography In Rheumatoid Arthritis Study","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":4000,"lead_sponsor_name":"Ellen Margrethe Hauge","has_results":false},{"nct_id":"NCT07419555","title":"Belgian Lung Function Study","phase":"","overall_status":"RECRUITING","enrollment_count":4000,"lead_sponsor_name":"KU Leuven","has_results":false},{"nct_id":"NCT03659838","title":"Luftibus in the School: a Study on the Respiratory Health of Schoolchildren.","phase":"","overall_status":"COMPLETED","enrollment_count":3500,"lead_sponsor_name":"University Children's Hospital, Zurich","has_results":false},{"nct_id":"NCT04695093","title":"Children's Health in London and Luton (CHILL)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3312,"lead_sponsor_name":"Queen Mary University of London","has_results":false},{"nct_id":"NCT05913700","title":"Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3067,"lead_sponsor_name":"Institute for Clinical Effectiveness, Japan","has_results":false},{"nct_id":"NCT02943551","title":"Dialogue Around Respiratory Illness Treatment","phase":"NA","overall_status":"UNKNOWN","enrollment_count":2728,"lead_sponsor_name":"Seattle Children's Hospital","has_results":false},{"nct_id":"NCT05246137","title":"A Phase III Trial to Assess the Safety and Immunogenicity of a HIPRA's Candidate Booster Vaccination Against COVID-19.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2646,"lead_sponsor_name":"Hipra Scientific, S.L.U","has_results":false},{"nct_id":"NCT04581096","title":"Mapping COVID-19 Spread in a Tertiary Hospital","phase":"","overall_status":"COMPLETED","enrollment_count":2646,"lead_sponsor_name":"Hospital General Universitario de Valencia","has_results":false},{"nct_id":"NCT04845048","title":"Active Pharmacovigilance Study of Adsorbed COVID-19 (Inactivated) Vaccine","phase":"","overall_status":"COMPLETED","enrollment_count":2549,"lead_sponsor_name":"Butantan Institute","has_results":false},{"nct_id":"NCT06931782","title":"AI in Respiratory Disease Prevention, Diagnosis, and Triage","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2400,"lead_sponsor_name":"The First Affiliated Hospital of Guangzhou Medical University","has_results":false},{"nct_id":"NCT05225298","title":"SARS-COV-2 Screening in Dialysis Facilities","phase":"NA","overall_status":"COMPLETED","enrollment_count":2389,"lead_sponsor_name":"Stanford University","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}